AZN · Categories · Downgrades

AZN - Analyst downgrades

AstraZeneca PLC (AZN) analyst downgrades - real-time wire coverage filtered to Downgrades only.

Recent Downgrades for AZN

• 249d
  AstraZeneca downgraded by Deutsche Bank

  Deutsche Bank downgraded AstraZeneca from Hold to Sell
• 647d
  AstraZeneca downgraded by Deutsche Bank

  Deutsche Bank downgraded AstraZeneca from Hold to Sell
• 865d
  AstraZeneca downgraded by Deutsche Bank

  Deutsche Bank downgraded AstraZeneca from Hold to Sell
• 901d
  AstraZeneca downgraded by Jefferies with a new price target

  Jefferies downgraded AstraZeneca from Buy to Hold and set a new price target of $70.00 from $78.50 previously
• 1083d
  AstraZeneca downgraded by Deutsche Bank

  Deutsche Bank downgraded AstraZeneca from Buy to Hold
• 1376d
  AstraZeneca downgraded by Credit Suisse

  Credit Suisse downgraded AstraZeneca from Outperform to Neutral
• 1384d
  AstraZeneca downgraded by Morgan Stanley

  Morgan Stanley downgraded AstraZeneca from Overweight to Equal-Weight
• 1469d
  AstraZeneca downgraded by UBS

  UBS downgraded AstraZeneca from Buy to Neutral
• 1658d
  AstraZeneca downgraded by Jefferies

  Jefferies downgraded AstraZeneca from Buy to Hold
• 1897d
  AstraZeneca downgraded by Argus

  Argus downgraded AstraZeneca from Buy to Hold

Other AZN categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings